Dexamethasone inhibits small intestinal growth via increased protein catabolism in neonatal pigs

American Journal of Physiology - Endocrinology and Metabolism

Volumn 276, Issue 2 39-2, 1999, Pages

  Burrin, Douglas G ^a,c   Wester, Timothy J ^a,b   Davis, Teresa A ^a   Fiorotto, Marta L ^a   Chang, Xiaoyan ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c CHILDREN S NUTRITION RESEARCH CENTER   (United States)

Author keywords

Glucocorticoids; Insulin like growth factor binding proteins; Insulin like growth factor I; Lactase; Protein synthesis

Indexed keywords

DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ILEUM; IMMUNOBLOTTING; INTESTINE VILLUS; JEJUNUM; MORPHOLOGY; NEWBORN; NONHUMAN; ORGAN WEIGHT; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SMALL INTESTINE; SUBCUTANEOUS DRUG ADMINISTRATION; SWINE;

EID: 0032986808     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.276.2.e269     Document Type: Article

References (48)

1. Adamo, M., H. Werner, W. Farnsworth, C. T. Roberts, Jr., M. Raizada, and D. LeRoith. Dexamethasone reduces steady state insulin-like growth factor I messenger ribonucleic acid levels in rat neuronal and glial cells in primary culture. Endocrinology 123: 2565-2570, 1988.
2. Bamberger, C. M., H. M. Schulte, and G. P. Chrousos. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 17: 245-259, 1996.
3. Beckett, P. R., M. L. Fiorotto, T. A. Davis, and P. J. Reeds. Corticosterone has independent effects on tissue maturation and growth in the suckling rat. Pediatr. Res. 39: 395-400, 1996.
4. Brownlee, K. G., P. C. Ng, M. J. Henderson, M. Smith, J. H. Green, and P. R. F. Dear. Catabolic effect of dexamethasone in the preterm baby. Arch. Dis. Child. 61: 1-4, 1992.
5. Burrin, D. G., T. A. Davis, S. Ebner, P. Schoknecht, M. Fiorotto, P. J. Reeds, and S. McAvoy. Nutrient-independent and nutrient-dependent factors stimulate protein synthesis in colostrum-fed newborn pigs. Pediatr. Res. 37: 1-7, 1995.
6. Burrin, D. G., T. J. Wester, T. A. Davis, S. Amick, and J. P. Heath. Orally administered IGF-I increases intestinal mucosal growth in formula-fed neonatal pigs. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R1085-R1091, 1996.
7. Buts, J. P., and R. DeMeyer. Intestinal development in the suckling rat: effects of weaning, diet composition, and glucocorticoids on thymidine kinase activity and DNA synthesis. Pediatr. Res. 18: 145-150, 1984.
8. Chapple, R. P., J. A. Cuaron, and R. A. Easter. Temporal changes in carbohydrate digestive capacity and growth rate of piglets in response to glucocorticoid administration and weaning age. J. Anim. Sci. 67: 2985-2995, 1989.
9. Cummings, J. J., D. B. D'Eugenio, and S. J. Gross. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N. Engl. J. Med. 320: 1505-1510, 1989.
10. 3]leucine. Am. J. Physiol. 267 (Gastrointest. Liver Physiol. 30): G1128-G1134, 1994.
11. Dixon, W. J. BMDP Statistical Software. Los Angeles: Univ. Of California Press, 1990.
12. Fussell, J. C., and F. J. Kelly. Effects of dexamethasone on lung protein turnover. Biochem. J. 273: 93-97, 1991.
13. 3H]phenylalanine. Biochem. J. 192: 719-723, 1980.
14. Giorgino, F., and R. J. Smith. Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways. J. Clin. Invest. 96: 1473-1483, 1995.
15. Hellstern, G., D. J. Reijngoud, F. Stellaard, and A. Okken. Insulin-like growth factor-I fails to reverse corticosteroid-induced protein catabolism in growing piglets. Pediatr. Res. 39: 421-426, 1996.
16. Henning, S. J., P. L. Ballard, and N. Kretchmer. A study of the cytoplasmic receptors for glucocorticoids in intestine of pre-and postweanling rats. J. Biol. Chem. 250: 2073-2079, 1975.
17. Henning, S. J., D. C. Rubin, and R. J. Shulman. Ontogeny of the intestinal mucosa. In: Physiology of the Gastrointestinal Tract, edited by L. R. Johnson. New York: Raven, 1994, p. 571-610.
18. Herbst, J. J., and O. Koldovsky. Cell migration and cortisone induction of sucrase activity in the jejunum and ileum. Biochem. J. 126: 471-476, 1972.
19. Hong, D. H., and N. E. Forsberg. Effects of dexamethasone on protein degradation and protease gene expression in rat L8 myotube cultures. Mol. Cell. Endocrinol. 108: 199-209, 1995.
20. Horber, F. F., and M. W. Haymond. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J. Clin. Invest. 86: 265-272, 1990.
21. Isozaki, U., W. E. Mitch, B. K. England, and S. R. Price. Protein degradation and increased mRNAs encoding proteins of the ubiquitin-proteasome proteolytic pathway in BC3H1 myocytes require an interaction between glucocorticoids and acidification. Proc. Natl. Acad. Sci. USA 93: 1967-1971, 1996.
22. Jones, J. I., and D. R. Clemmons. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16: 3-34, 1995.
23. Kelly, F. J., and D. F. Goldspink. The differing responses of four muscle types to dexamethasone treatment in the rat. Biochem. J. 208: 147-151, 1982.
24. Labarca, C., and K. Paigen. A simple, rapid and sensitive DNA assay procedure. Anal. Biochem. 102: 344-352, 1980.
25. Lee, C. Y., F. W. Bazer, T. D. Etherton, and F. A. Simmen. Ontogeny of insulin-like growth factors (IGF-I and IGF-II) and IGF-binding proteins in porcine serum during fetal and postnatal development. Endocrinology 128: 2336-2344, 1991.
26. LeRoith, D., H. Werner, D. Beitner-Johnson, and C. T. Roberts. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16: 143-163, 1995.
27. Lo, H. C., and D. M. Ney. GH and IGF-I differentially increase protein synthesis in skeletal muscle and jejunum of parenterally fed rats. Am. J. Physiol. 271 (Endocrinol. Metab. 34): E872-E878, 1996.
28. Luo, J., and L. J. Murphy. Regulation of insulin-like growth factor binding protein-3 expression by dexamethasone. Mol. Cell. Endocrinol. 74: 213-219, 1990.
29. Luo, J., R. E. Reid, and L. J. Murphy. Dexamethasone increases hepatic insulin-like growth factor binding protein-1 (IGFBP-1) mRNA and serum IGFBP-1 concentrations in the rat. Endocrinology 127: 1456-1462, 1990.
30. Mammel, M. C., T. P. Green, D. E. Johnson, and T. R. Thompson. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1: 1356-1358, 1983.
31. McCusker, R. H., W. S. Cohick, W. H. Busby, and D. R. Clemmons. Evaluation of the developmental and nutritional changes in porcine insulin-like growth factor binding protein-1 and protein-2 serum levels by immunoassay. Endocrinology 129: 2631-2638, 1991.
32. Park, J. H. Y., R. H. McCusker, H. Mohammadpour, D. J. Blackwood, M. Hrbek, and J. A. Vanderhoof. Dexamethasone inhibits mucosal adaptation after small bowel resection. Am. J. Physiol. 266 (Gastrointest. Liver Physiol. 29): G497-G503, 1994.
33. Price, W. A., A. D. Stiles, B. M. Moats-Staats, and A. J. D'Ercole. Gene expression of insulin-like growth factors (IGFs), the type I IGF receptor, and IGF-binding proteins in dexamethasone-induced fetal growth retardation. Endocrinology 130: 1424-1432, 1992.
34. Raul, F., B. Lacroix, and M. Aprahamian. Longitudinal distribution of brush border hydrolases and morphological maturation in the intestine of the preterm infant. Early Hum. Dev. 13: 225-234, 1986.
35. Read, L. C., F. M. Tomas, G. S. Howarth, A. A. Martin, K. J. Edson, C. M. Gillespie, P. C. Owens, and F. J. Ballard. Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats. J. Endocrinol. 33: 421-431, 1992.
36. Sangild, P. T. Perinatal development of gut enzyme activity: intrinsic mechanism versus external influences. Proc. Int. Symp. Digest. Physiol. Pigs 7th Rome 1997, p. 118-126. (Eur. Assoc. Anim. Prod.)
37. Sangild, P. T. Stimulation of gastric proteases in the neonatal pig by a rise in adrenocortical secretion at parturition. Reprod. Fertil. Dev. 7: 1293-1298. 1995.
38. Sangild, P. T., M. Silver, A. L. Fowden, A. Turvey, and B. Foltmann. Adrenocortical stimulation of stomach development in the prenatal pig. Biol. Neonate 65: 378-389. 1994.
39. Shimasaki, S., and N. L. Ling. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog. Growth Factor Res. 3: 243-266, 1991.
40. Skinner, A. M., M. Battin, A. Solimano, J. Daaboul, and H. F. Kitson. Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia. Am. J. Perinatol. 14: 539-546, 1997.
41. Trahair, J. F., R. A. Perry, M. Silver, and P. M. Robinson. Studies on the maturation of the small intestine in the fetal sheep. II. The effects of exogenous cortisol. Q. J. Exp. Physiol. 72: 71-79, 1987.
42. Tsuboi, K. K., L. K. Kwong, P. Sunshine, and R. O. Castillo. Mechanism of maturational decline of rat intestinal lactase-phlorizin hydrolase. Biochem. J. 282: 107-113, 1992.
43. Van Goudoever, J. B., J. D. L. Wattimena, V. P. Carnielli, E. J. Sulkers, H. J. Degenhart, and P. J. J. Sauer. Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia. J. Pediatr. 124: 112-118, 1994.
44. Villafuerte, B. C., B. L. Koop, C. I. Pao, and L. S. Phillips. Glucocorticoid regulation of insulin-like growth factor-binding protein-3. Endocrinology 136: 1928-1933, 1995.
45. Weiler, H. A., Z. Wang, and S. A. Atkinson. Whole body lean mass is altered by DEX treatment through reductions in protein and energy utilization in piglets. Biol. Neonate 71: 53-59, 1997.
46. Wester, T. J., T. A. Davis, M. L. Fiorotto, and D. G. Burrin. Exogenous growth hormone stimulates somatotrophic axis function and growth in neonatal pigs. Am. J. Physiol. 274 (Endocrinol. Metab. 37): E29-E37, 1998.
47. Williams, A. F., and M. Jones. Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia. Arch. Dis. Child. 67: 5-9, 1992.
48. Yang, H., M. Grahn, D. S. Schalch, and D. M. Ney. Anabolic effects of IGF-I coinfused with total parenteral nutrition in DEX-treated rats. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E690-E698, 1994.